Nano‐immunotherapy has been recognized as a highly promising strategy for cancer treatment in recent decades, which combines nanotechnology and immunotherapy to combat against tumors. Hybrid nanomaterials consisting of at least two constituents with distinct compositions and properties, usually organic and inorganic, have been engineered with integrated functions and enormous potential in boosting cancer immunotherapy. This review provides a summary of hybrid nanomaterials reported for cancer immunotherapy, including nanoscale metal–organic frameworks, metal–phenolic networks, mesoporous organosilica nanoparticles, metallofullerene nanomaterials, polymer–lipid, and biomacromolecule‐based hybrid nanomaterials. The combination of immunotherapy with chemotherapy, chemodynamic therapy, radiotherapy, radiodynamic therapy, photothermal therapy, photodynamic therapy, and sonodynamic therapy based on hybrid nanomaterials is also discussed. Finally, the current challenges and the prospects for designing hybrid nanomaterials and their application in cancer immunotherapy are outlined.
The synthesized Fe3O4@Mg-MOF-74 core–shell nanoparticles show effective and selective enrichment of 441 N-glycosylation sites of 418 glycopeptides from 125 glycoproteins in 1 μL of human serum.
A 2D phosphonate MOF {[Ni(Hptz)2]·7H2O}n (H2ptz = 4-(1,2,4-triazol-4-yl)phenylphosphonic acid) (2) is obtained through crystal transformation from a trinuclear compound [Ni3(Hptz)6·(H2O)6]·9H2O (1). Studies of chemical stability show that 2 retains its crystallinity in boiling water and organic solvents. 2 also exhibits high adsorption capacity for CO2 (80 cm3(STP) g−1) and selective separation of CO2 over N2.
A three-dimensional (3D) metal–organic framework {[Zn2(HBDC)2(dmtrz)2]·guest}n with pcu net has been solvothermally synthesized, which shows selective adsorption of linear and monobranched hexane isomers over a dibranched one.